Related Experiment Videos
Cytokine neutralizing strategies in experimental sepsis
1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.
Progress in Clinical and Biological Research
|January 1, 1994
Summary
Cytokine cascades from endotoxemia and bacteremia can cause sepsis and death. Researchers are exploring new strategies beyond antibody neutralization to manage these severe inflammatory responses.
Area of Science:
- Immunology
- Sepsis Pathophysiology
- Inflammatory Response
Background:
- Endotoxemia and bacteremia trigger cytokine cascades, crucial for host defense but potentially lethal in exaggerated forms.
- Sepsis and shock result from uncontrolled cytokine responses, prompting extensive research into neutralization strategies.
- Current methods focus on neutralizing specific cytokines like TNF and IL-1 via antibodies, but face significant practical and financial barriers.
Purpose of the Study:
- To review alternative and promising strategies for managing cytokine dysregulation in sepsis.
- To highlight novel therapeutic avenues beyond traditional antibody-based neutralization.
Main Methods:
- Review of experimental and clinical investigations into sepsis and cytokine modulation.
- Analysis of emerging therapeutic strategies for controlling cytokine cascades.
Main Results:
- Traditional antibody neutralization of cytokines faces biological and economic challenges, limiting clinical application.
- Several alternative strategies show promise in preclinical and clinical investigations.
Conclusions:
- Novel approaches including natural cytokine antagonists, enhanced clearance, dietary modulation, and gene therapy offer potential solutions for sepsis management.
- Further research into these alternative strategies is warranted to overcome the limitations of current treatments.